cetylpyridinium chloride anhydrous has been researched along with Diabetic Neuropathies in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cagiltay, E; Celik, S; Ipcioglu, O; Kucukardali, Y; Oktenli, C; Ozata, M; Sahan, B; Sayan, O; Senol, MG; Terekeci, HM; Top, C | 1 |
| Biniszkiewicz, T; Cieślar, G; Grzeszczak, W; Hajdrowska, B; Karasek, D; Rawwash, HA; Sieroń, A; Sieroń-Stołtny, K; Strojek, K; Strzelczyk, JK; Szymborska-Kajanek, A; Wiczkowski, A; Wróbel, M | 1 |
| Kazakos, KA; Sarafidis, PA; Yovos, JG | 1 |
2 trial(s) available for cetylpyridinium chloride anhydrous and Diabetic Neuropathies
| Article | Year |
|---|---|
Impact of low-frequency pulsed magnetic fields on defensin and CRP concentrations in patients with painful diabetic polyneuropathy and in healthy subjects.
Topics: Adult; C-Reactive Protein; Case-Control Studies; Defensins; Diabetic Neuropathies; Electromagnetic Fields; Female; Health; Humans; Male; Middle Aged | 2010 |
The impact of diabetic autonomic neuropathy on the incretin effect.
Topics: Adult; C-Peptide; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Female; Health; Humans; Incretins; Insulin; Insulin Secretion; Insulin-Secreting Cells; Male | 2008 |
1 other study(ies) available for cetylpyridinium chloride anhydrous and Diabetic Neuropathies
| Article | Year |
|---|---|
Plasma osteoprotegerin concentrations in type 2 diabetic patients and its association with neuropathy.
Topics: Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Female; Health; Humans; Male; Middle Aged; Osteoprotegerin | 2009 |